Mereo BioPharma begins BPS-804 mid-stage trial in osteogenesis imperfecta
British specialty biopharma company Mereo BioPharma Group has wrapped up enrollment of patients for a phase 2b clinical trial that
Continue readingCoverage of Global Pharma Industry News
British specialty biopharma company Mereo BioPharma Group has wrapped up enrollment of patients for a phase 2b clinical trial that
Continue readingThe European Commission (EC) has approved a label update for Novartis psoriatic arthritis drug Cosentyx (secukinumab) to include dosing flexibility
Continue readingNordic Nanovector has opened its first clinical site in the US at Long Beach in California for the PARADIGME trial
Continue readingGalecto Biotech, a Denmark-based pharma company focused on developing galectin modulators for the treatment of severe diseases such as idiopathic
Continue readingAlliqua acquisition of Adynxx : Pennsylvania-based Alliqua BioMedical has agreed to merge with San Francisco-based biopharma company Adynxx to form
Continue readingMylan has launched Hulio, a biosimilar to AbbVie’s Humira (adalimumab), in major markets in Europe, a month after its approval
Continue readingTWi Biotechnology, a Taiwanese biotech company, has announced the enrollment of the first patient in a phase 2 trial evaluating
Continue readingDupixent FDA approval : Dupixent (dupilumab), an eczema drug the co-developed by Sanofi and Regeneron Pharmaceuticals, has been approved by the
Continue readingSwiss pharma giant Novartis has signed a deal valued at about $2.1 billion to acquire US biopharma company Endocyte in
Continue readingQuotient Sciences, a UK-based drug development services provider, has expanded its operations in the US by opening an early phase
Continue reading